Home › Bleeding › Indiana › Indianapolis
Bleeding clinical trials in Indianapolis, IN
5 studies for Bleeding are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
RecruitingPhase 3
- Innovative Hematology, Inc., Indianapolis
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
RecruitingPhase 2
- Indiana University, Indianapolis
- Blue Coast Research Center, LLC, Indianapolis
- Franciscan Physician Network, Indiana Heart Physicians, Indianapolis
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Innovative Hematology, Inc., Indianapolis
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Innovative Hematology, Inc., Indianapolis
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
RecruitingPhase 3
- Indiana University, Indianapolis
About Bleeding
Bleeding is the loss of blood, inside or outside the body. A hemorrhage is severe bleeding. Learn about the causes of bleeding and how to treat it.
More about Bleeding on MedlinePlus
Bleeding trials in other cities
- Boston, MA10 studies
- New York City, NY8 studies
- Houston, TX7 studies
- Atlanta, GA6 studies
- Cleveland, OH6 studies
- Chicago, IL6 studies
- Philadelphia, PA5 studies
- Seattle, WA5 studies
- Durham, NC5 studies
- St. Louis, MO5 studies
- San Diego, CA4 studies
- Cedar Rapids, IA4 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure23 studies
- Breast Cancer20 studies
- Obesity20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Lung Cancer16 studies
- Cardiovascular Disease16 studies
- Type 1 Diabetes14 studies
- Endometrial Cancer14 studies
From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.